These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 22610535)
1. The oxysterol receptors LXRα and LXRβ suppress proliferation in the colon. Vedin LL; Gustafsson JÅ; Steffensen KR Mol Carcinog; 2013 Nov; 52(11):835-44. PubMed ID: 22610535 [TBL] [Abstract][Full Text] [Related]
2. Modulation of liver X receptor signaling as a prevention and therapy for colon cancer. Chuu CP Med Hypotheses; 2011 May; 76(5):697-9. PubMed ID: 21333456 [TBL] [Abstract][Full Text] [Related]
3. LXRα-mediated downregulation of FOXM1 suppresses the proliferation of hepatocellular carcinoma cells. Hu C; Liu D; Zhang Y; Lou G; Huang G; Chen B; Shen X; Gao M; Gong W; Zhou P; Dai S; Zeng Y; He F Oncogene; 2014 May; 33(22):2888-97. PubMed ID: 23812424 [TBL] [Abstract][Full Text] [Related]
4. Activation of LXRs using the synthetic agonist GW3965 represses the production of pro-inflammatory cytokines by murine mast cells. Nunomura S; Okayama Y; Matsumoto K; Hashimoto N; Endo-Umeda K; Terui T; Makishima M; Ra C Allergol Int; 2015 Sep; 64 Suppl():S11-7. PubMed ID: 26344074 [TBL] [Abstract][Full Text] [Related]
5. Simultaneous activation of the liver X receptors (LXRα and LXRβ) drives murine collagen-induced arthritis disease pathology. Asquith DL; Miller AM; Reilly J; Kerr S; Welsh P; Sattar N; McInnes IB Ann Rheum Dis; 2011 Dec; 70(12):2225-8. PubMed ID: 21859686 [TBL] [Abstract][Full Text] [Related]
6. Activation of liver X receptors inhibits pancreatic islet beta cell proliferation through cell cycle arrest. Meng ZX; Nie J; Ling JJ; Sun JX; Zhu YX; Gao L; Lv JH; Zhu DY; Sun YJ; Han X Diabetologia; 2009 Jan; 52(1):125-35. PubMed ID: 18949453 [TBL] [Abstract][Full Text] [Related]
7. Identification of 5α, 6α-epoxycholesterol as a novel modulator of liver X receptor activity. Berrodin TJ; Shen Q; Quinet EM; Yudt MR; Freedman LP; Nagpal S Mol Pharmacol; 2010 Dec; 78(6):1046-58. PubMed ID: 20837678 [TBL] [Abstract][Full Text] [Related]
8. Separate and overlapping metabolic functions of LXRalpha and LXRbeta in C57Bl/6 female mice. Korach-André M; Parini P; Larsson L; Arner A; Steffensen KR; Gustafsson JA Am J Physiol Endocrinol Metab; 2010 Feb; 298(2):E167-78. PubMed ID: 19690071 [TBL] [Abstract][Full Text] [Related]
9. Liver X receptors inhibit proliferation of human colorectal cancer cells and growth of intestinal tumors in mice. Lo Sasso G; Bovenga F; Murzilli S; Salvatore L; Di Tullio G; Martelli N; D'Orazio A; Rainaldi S; Vacca M; Mangia A; Palasciano G; Moschetta A Gastroenterology; 2013 Jun; 144(7):1497-507, 1507.e1-13. PubMed ID: 23419360 [TBL] [Abstract][Full Text] [Related]
10. Regulation of the aldo-keto reductase gene akr1b7 by the nuclear oxysterol receptor LXRalpha (liver X receptor-alpha) in the mouse intestine: putative role of LXRs in lipid detoxification processes. Volle DH; Repa JJ; Mazur A; Cummins CL; Val P; Henry-Berger J; Caira F; Veyssiere G; Mangelsdorf DJ; Lobaccaro JM Mol Endocrinol; 2004 Apr; 18(4):888-98. PubMed ID: 14739254 [TBL] [Abstract][Full Text] [Related]
11. The oxysterol receptor LXRβ protects against DSS- and TNBS-induced colitis in mice. Jakobsson T; Vedin LL; Hassan T; Venteclef N; Greco D; D'Amato M; Treuter E; Gustafsson JÅ; Steffensen KR Mucosal Immunol; 2014 Nov; 7(6):1416-28. PubMed ID: 24803164 [TBL] [Abstract][Full Text] [Related]
12. Skeletal muscle as a target of LXR agonist after long-term treatment: focus on lipid homeostasis. Archer A; Laurencikiene J; Ahmed O; Steffensen KR; Parini P; Gustafsson JÅ; Korach-André M Am J Physiol Endocrinol Metab; 2014 Mar; 306(5):E494-502. PubMed ID: 24368671 [TBL] [Abstract][Full Text] [Related]
13. The oxysterol receptor LXR inhibits proliferation of human breast cancer cells. Vedin LL; Lewandowski SA; Parini P; Gustafsson JA; Steffensen KR Carcinogenesis; 2009 Apr; 30(4):575-9. PubMed ID: 19168586 [TBL] [Abstract][Full Text] [Related]
14. LXR{beta} is the dominant LXR subtype in skeletal muscle regulating lipogenesis and cholesterol efflux. Hessvik NP; Boekschoten MV; Baltzersen MA; Kersten S; Xu X; Andersén H; Rustan AC; Thoresen GH Am J Physiol Endocrinol Metab; 2010 Mar; 298(3):E602-13. PubMed ID: 19996385 [TBL] [Abstract][Full Text] [Related]
15. Liver × receptor ligands disrupt breast cancer cell proliferation through an E2F-mediated mechanism. Nguyen-Vu T; Vedin LL; Liu K; Jonsson P; Lin JZ; Candelaria NR; Candelaria LP; Addanki S; Williams C; Gustafsson JÅ; Steffensen KR; Lin CY Breast Cancer Res; 2013 Jun; 15(3):R51. PubMed ID: 23809258 [TBL] [Abstract][Full Text] [Related]
16. Fasting-induced FGF21 is repressed by LXR activation via recruitment of an HDAC3 corepressor complex in mice. Archer A; Venteclef N; Mode A; Pedrelli M; Gabbi C; Clément K; Parini P; Gustafsson JÅ; Korach-André M Mol Endocrinol; 2012 Dec; 26(12):1980-90. PubMed ID: 23073827 [TBL] [Abstract][Full Text] [Related]
17. Liver X receptor ligand cytotoxicity in colon cancer cells and not in normal colon epithelial cells depends on LXRβ subcellular localization. Courtaut F; Derangère V; Chevriaux A; Ladoire S; Cotte AK; Arnould L; Boidot R; Rialland M; Ghiringhelli F; Rébé C Oncotarget; 2015 Sep; 6(29):26651-62. PubMed ID: 26450852 [TBL] [Abstract][Full Text] [Related]
18. Liver X receptors interfere with the deleterious effect of diethylstilbestrol on testicular physiology. Oumeddour A; Viennois E; Caira F; Decourbey C; Maqdasy S; Tahraoui A; Baron S; Volle DH; Lobaccaro JM Biochem Biophys Res Commun; 2014 Apr; 446(3):656-62. PubMed ID: 24333430 [TBL] [Abstract][Full Text] [Related]
19. Liver X receptor activators display anti-inflammatory activity in irritant and allergic contact dermatitis models: liver-X-receptor-specific inhibition of inflammation and primary cytokine production. Fowler AJ; Sheu MY; Schmuth M; Kao J; Fluhr JW; Rhein L; Collins JL; Willson TM; Mangelsdorf DJ; Elias PM; Feingold KR J Invest Dermatol; 2003 Feb; 120(2):246-55. PubMed ID: 12542530 [TBL] [Abstract][Full Text] [Related]
20. Overlapping transcriptional programs regulated by the nuclear receptors peroxisome proliferator-activated receptor alpha, retinoid X receptor, and liver X receptor in mouse liver. Anderson SP; Dunn C; Laughter A; Yoon L; Swanson C; Stulnig TM; Steffensen KR; Chandraratna RA; Gustafsson JA; Corton JC Mol Pharmacol; 2004 Dec; 66(6):1440-52. PubMed ID: 15371561 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]